BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31951967)

  • 1. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
    Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
    Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between serum IL-9 levels and Behçet's disease.
    Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
    Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Exploration of Some Predictors of Quality of Life-Related to the Innate Immune System, Inflammation, and Disease Activity in Patients with Behcet's Syndrome: An Analytical Cross-sectional Study.
    Faghfouri AH; Shoura SMS; Papi S; Khabbazi A; Baradaran B; Badpeyma M; Faghfuri E
    Curr Rheumatol Rev; 2024; 20(2):200-207. PubMed ID: 37691223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of Th17 to Th1 cells in Behçet's disease.
    Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial.
    Faghfouri AH; Khabbazi A; Baradaran B; Khajebishak Y; Baghbani E; Noorolyai S; Rahmani S; Seyyed Shoura SM; Alipour M; Alipour B
    Clin Nutr; 2022 May; 41(5):1083-1092. PubMed ID: 35413570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
    Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population.
    Shahriyari E; Bonyadi M; Jabbarpoor Bonyadi MH; Soheilian M; Yaseri M; Ebrahimiadib N
    Curr Eye Res; 2019 Feb; 44(2):200-205. PubMed ID: 30289285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
    Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
    J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of HLA-B5, HLA-B51 and HLA-B27 in patients with idiopathic uveitis and Behçet's disease: a case-control study.
    Shenavandeh S; Jahanshahi KA; Aflaki E; Tavassoli A
    Reumatologia; 2018; 56(2):67-72. PubMed ID: 29853720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine, C-Reactive Protein, and Heat Shock Protein mRNA Expression Levels in Patients with Active Behçet's Uveitis.
    Balkan E; Bilen H; Eyerci N; Keleş S; Kara A; Akdeniz N; Dogan H
    Med Sci Monit; 2018 Mar; 24():1511-1516. PubMed ID: 29534057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
    Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The performance of different classification criteria in paediatric Behçet's disease.
    Batu ED; Sönmez HE; Sözeri B; Butbul Aviel Y; Bilginer Y; Özen S
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):119-123. PubMed ID: 28406761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.